Staan Biomed Engineering Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
- Paid Up Capital ₹ 6.00 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.77 Cr
- Satisfied Charges ₹ 1.43 Cr
- Revenue Growth 10.27%
- Profit Growth 31.59%
- Ebitda 33.68%
- Net Worth 21.30%
- Total Assets 12.78%
About Staan Biomed Engineering
Staan Biomed Engineering Private Limited (SBEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 July 2003 and has a history of 21 years and seven months. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹18.77 Cr. The company has closed loans amounting to ₹1.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Maria Stanley, Antony Sagayaraj, Antonyarmstrong Michalraj, and One other member serve as directors at the Company.
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51507TZ2003PTC010665
- Company No.
010665
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
What products or services does Staan Biomed Engineering Private Limited offer?
Staan Biomed Engineering Private Limited offers a wide range of products and services, including Elevators & Escalators, Elevator Doors, Surgical & ICU Equipments, Medical Pumps, Forceps & Graspers, Surgical Scalpels, Orthopedic Equipment & Supplies, Orthopedic Surgical Instruments, Orthopedic Instruments, OT Tables.
Who are the key members and board of directors at Staan Biomed Engineering?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Maria Stanley ![]() | Managing Director | 10-Jul-2003 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Antony Sagayaraj ![]() | Whole-Time Director | 10-Jul-2003 | Current |
Antonyarmstrong Michalraj ![]() | Whole-Time Director | 10-Jul-2003 | Current |
Ralph Maria | Director | 30-Sep-2024 | Current |
Financial Performance of Staan Biomed Engineering.
Staan Biomed Engineering Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 10.27% increase. The company also saw a substantial improvement in profitability, with a 31.59% increase in profit. The company's net worth Soared by an impressive increase of 21.3%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Staan Biomed Engineering?
In 2023, Staan Biomed Engineering had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹187.66 M
₹14.33 M
Charges Breakdown by Lending Institutions
- Indian Bank : 10.77 Cr
- The Catholic Syrian Bank Ltd : 8.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 Nov 2024 | Indian Bank | ₹2.00 M | Open |
15 Mar 2024 | Indian Bank | ₹8.90 Cr | Open |
16 Feb 2024 | Indian Bank | ₹1.30 Cr | Open |
19 Oct 2023 | Indian Bank | ₹3.00 M | Open |
21 Mar 2019 | Indian Bank | ₹0.66 M | Open |
How Many Employees Work at Staan Biomed Engineering?
Staan Biomed Engineering has a workforce of 56 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Staan Biomed Engineering, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Staan Biomed Engineering's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.